Inici del seminari Towards the targeted therapy for triple negative breast cancer using nanoparticles, iPeps and CRISPR-dCas9 technology.
- Lloc:
- Unitat docent de l'Arnau de Vilanova (Ciències de la Salut)
- Inici:
- |
Inici del seminari Towards the targeted therapy for triple negative breast cancer using nanoparticles, iPeps and CRISPR-dCas9 technology, a càrrec d'Anabel Sorolla (Harry Perkins Institute of Medical Research-The University of Western Australia).